Assistant Professor, Internal Medicine, University of Missouri, Kansas City School of Medicine
Cardiology
Dr. Adnan K. Chhatriwalla, MD
|
|
Give Review
Adnan K. Chhatriwalla works in the field of Cardiology. He went to medical school at Case Western Reserve University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Adnan Chhatriwalla is a published doctor. He published 27 publications, including: 'Combined Transcatheter Aortic Valve Replacement and Thoracic Endovascular Aortic Repair Using Transapical Access.' He accepts Medicare.
Publications
- Combined Transcatheter Aortic Valve Replacement and Thoracic Endovascular Aortic Repair Using Transapical Access.
- Improving the process of informed consent for percutaneous Coronary intervention: patient outcomes from the Patient Risk Information Services Manager (ePRISM) study.
- The Kidney Connection: Holy Grail or Wild Goose Chase?
- Costs of transradial percutaneous Coronary intervention.
- Association between bleeding events and in-hospital mortality after percutaneous Coronary intervention.
- Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status.
- Pre-procedural estimate of individualized bleeding risk impacts physicians' utilization of bivalirudin during percutaneous Coronary intervention.
- Recurrent stent fracture in the right Coronary artery.
- Fulminant myocarditis due to H1N1 influenza.
- Limitations of angiography for the assessment of renal Artery stenosis and treatment implications.
- Drug-eluting stent fracture and Acute coronary syndrome.
- Role of invasive evaluation with cineradiography and intracardiac echocardiography to detect mechanical prosthetic Valve dysfunction.
- Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia.
- Low levels of low-density lipoprotein cholesterol and blood pressure and progression of Coronary atherosclerosis.
- Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued ...
- Preliminary data on the diagnostic accuracy of rubidium-82 cardiac PET perfusion imaging for the evaluation of ischemia in a pediatric population.
- Measurement of left ventricular mass by contrast ventriculography.
- Breaking with tradition: is diagnostic angiography really necessary before Primary PCI?
- Walk this way: early ambulation after cardiac catheterization--good for the patient and the health care system.
- High left ventricular mass index does not limit the utility of fractional flow reserve for the physiologic assessment of lesion severity.
- An 8-month-old girl with an anomalous left Coronary artery from the pulmonary artery complicated by myocardial ischemia after surgical reimplantation.
- You can't keep a good man (or woman) down.
- Precision medicine to improve use of bleeding avoidance strategies and reduce bleeding in patients undergoing percutaneous Coronary intervention: prospective cohort st...
- The ASTEROID trial: Coronary plaque regression with high-dose statin therapy.
- Impact of statins on atherosclerotic plaque.
- Myocardial infarction secondary to a Coronary ostial thrombus in antiphospholipid syndrome.
Schools
Case Western Reserve University School of Medicine
University Virginia Hospital
Cleveland Clinic Foundation
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Cleveland Clinic Foundation -
University of Virginia -
Case Western Reserve University School of Medicine
Drug Facts
| NPI NUMBER | 1508035163 | |
| NPPES Provider LastName | CHHATRIWALLA | |
| NPPES Provider FirstName | ADNAN | |
| NPPES Provider ZIPCode | 641115939 | |
| NPPES Provider State | MO | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1621.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508035163 |
| Last Name Of The Provider | CHHATRIWALLA |
| First Name Of The Provider | ADNAN |
| View All |
Similar Doctors
|
|
Dr. Andrew C. Kao, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James E. Sear, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Safley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven B. Laster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Moe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark P. Everley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Holkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason B. Lindsey, MD |
|
|
Dr. Alan P. Wimmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mikhail Kosiborod, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David G. Skolnick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura M. Schmidt, MD |
|
|
Dr. Carlos E. Rivas-Gotz, MD |